Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation

Experimental Neurology

Volumn 271, Issue , 2015, Pages 506-514

  De Nuccio, C ^a   Bernardo, A ^a   Cruciani, C ^a   De Simone, R ^a   Visentin, S ^a   Minghetti, L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Mitochondria; Multiple sclerosis; Oligodendrocytes; PGC 1 ; PPAR ; TNF ; UCP2

Indexed keywords

ADENOSINE DIPHOSPHATE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT 1; DELTA12 PROSTAGLANDIN J2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; ROTENONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; ADENOSINE TRIPHOSPHATE; BRADYKININ; BRADYKININ ANTAGONIST; CALCIUM; CYCLOOXYGENASE 1; ION CHANNEL; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PTGS1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL VIABILITY; CONTROLLED STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PRIORITY JOURNAL; RAT; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CELL DIFFERENTIATION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OLIGODENDROGLIA; STEM CELL; TIME; WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; BRADYKININ; BRADYKININ RECEPTOR ANTAGONISTS; CALCIUM; CELL DIFFERENTIATION; CYCLOOXYGENASE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNELS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OLIGODENDROGLIA; PPAR GAMMA; RATS; RATS, WISTAR; ROTENONE; STEM CELLS; THIAZOLIDINEDIONES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938674555     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.07.014     Document Type: Article

References (28)

1. Agresti C., D'Urso D., Levi G. Reversible inhibitory effects of interferon-gamma and tumor necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 1996, 8(6):1106-1116. (Jun).
2. Agresti C., Meomartini M.E., Amadio S., Ambrosini E., Volonté C., Aloisi F., Visentin S. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors. Brain Res. Brain Res. Rev. 2005, 48(2):157-165. (Apr, Epub 2005 Jan 22. Review).
3. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001, 81(2):871-927. (Apr, Review).
4. Bernardo A., Bianchi D., Magnaghi V., Minghetti L. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J. Neuropathol. Exp. Neurol. 2009, 68(7):797-808. (Jul). 10.1097/NEN.0b013e3181aba2c1.
5. Black R.A. Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell Biol. 2002, 34(1):1-5. (Jan, Review).
6. Bonora M., De Marchi E., Patergnani S., Suski J.M., Celsi F., Bononi A., Giorgi C., Marchi S., Rimessi A., Duszyński J., Pozzan T., Wieckowski M.R., Pinton P. Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process. Cell Death Differ. 2014, 21(8):1198-1208. (Aug, Epub 2014 Mar 21). 10.1038/cdd.2014.35.
7. Bouillaud F. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim. Biophys. Acta 2009, 1787:377-383.
8. Caminero A., Comabella M., Montalban X. Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story. J. Neuroimmunol. 2011, 234(1-2):1-6. (May, Epub 2011 Apr 7. Review). 10.1016/j.jneuroim.2011.03.004.
9. de Bilbao F., Arsenijevic D., Vallet P., Hjelle O.P., Ottersen O.P., Bouras C., Raffin Y., Abou K., Langhans W., Collins S., Plamondon J., Alves-Guerra M.C., Haguenauer A., Garcia I., Richard D., Ricquier D., Giannakopoulos P. Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. J. Neurochem. 2004, 89:1283-1292.
10. De Nuccio C., Bernardo A., De Simone R., Mancuso E., Magnaghi V., Visentin S., Minghetti L. Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. J. Neuropathol. Exp. Neurol. 2011, 70(10):900-912. (Oct). 10.1097/NEN.0b013e3182309ab1.
11. Degasperi G.R., Romanatto T., Denis R.G., Araújo E.P., Moraes J.C., Inada N.M., Vercesi A.E., Velloso L.A. UCP2 protects hypothalamic cells from TNF-alpha-induced damage. FEBS Lett. 2008, 582(20):3103-3110. (Sep 3).
12. Feldhaus B., Dietzel I.D., Heumann R., Berger R. Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J. Soc. Gynecol. Investig. 2004, 11(2):89-96. (Feb).
13. Haak L.L., Grimaldi M., Russell J.T. Mitochondria in myelinating cells: calcium signaling in oligodendrocyte precursor cells. Cell Calcium 2000, 28(5-6):297-306. (Nov-Dec, Review. No abstract available).
14. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 1989, 170(2):607-612. (Aug 1).
15. Hondares E., Mora O., Yubero P., Rodriguez de la Concepción M., Iglesias R., Giralt M., Villarroya F. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation. Endocrinology 2006, 147(6):2829-2838. (Jun).
16. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., Warden C.H., Castilho R.F., Melcher T., Gonzalez-Zulueta M., Nikolich K., Wieloch T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 2003, 9(8):1062-1068. (Aug, Epub 2003 Jul 13).
17. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 2008, 5:45. (Oct 17, Review). 10.1186/1742-2094-5-45.
18. Miglio G., Rosa A.C., Rattazzi L., Collino M., Lombardi G., Fantozzi R. PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss. Neurochem. Int. 2009, 55(7):496-504. (Dec).
19. Rossi S., Furlan R., De Chiara V., Motta C., Studer V., Mori F., Musella A., Bergami A., Muzio L., Bernardi G., Battistini L., Martino G., Centonze D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann. Neurol. 2012, 71(1):76-83. (Jan).
20. Rossi S., Motta C., Studer V., Barbieri F., Buttari F., Bergami A., Sancesario G., Bernardini S., De Angelis G., Martino G., Furlan R., Centonze D. Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult. Scler. 2014, 20(3):304-312. (Mar).
21. Roth A.D., Leisewitz A.V., Jung J.E., Cassina P., Barbeito L., Inestrosa N.C., Bronfman M. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes. J. Neurosci. Res. 2003, 72(4):425-435. (May 15).
22. Schoenfeld R., Wong A., Silva J., Li M., Itoh A., Horiuchi M., Itoh T., Pleasure D., Cortopassi G. Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation. Mitochondrion 2010, 10(2):143-150. (Mar).
23. Shimokawa T., Kato M., Watanabe Y., Hirayama R., Kurosaki E., Shikama H., Hashimoto S. In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice. Biochem. Biophys. Res. Commun. 1998, 251(1):374-378. (Oct 9).
24. Thompson M.P., Kim D. Links between fatty acids and expression of UCP2 and UCP3 mRNAs. FEBS Lett. 2004, 568:4-9.
25. Vogler S., Pahnke J., Rousset S., Ricquier D., Moch H., Miroux B., Ibrahim S.M. Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. Am. J. Pathol. 2006, 168(5):1570-1575. (May).
26. Vozza A., Parisi G., De Leonardis F., Lasorsa F.M., Castegna A., Amorese D., Marmo R., Calcagnile V.M., Palmieri L., Ricquier D., Paradies E., Scarcia P., Palmieri F., Bouillaud F., Fiermonte G. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(3):960-965. (Jan 21).
27. Xiang Z., Valenza M., Cui L., Leoni V., Jeong H.K., Brilli E., Zhang J., Peng Q., Duan W., Reeves S.A., Cattaneo E., Krainc D. Peroxisome-proliferator-activated receptor gamma coactivator 1 a contributes to dysmyelination in experimental models of Huntington's disease. J. Neurosci. 2011, 31(26):9544-9553. (Jun 29).
28. Ziabreva I., Campbell G., Rist J., Zambonin J., Rorbach J., Wydro M.M., Lassmann H., Franklin R.J., Mahad D. Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 2010, 58(15):1827-1837. (Nov 15).